Implementing Precision Antimicrobial Therapy for the Treatment of Bovine Respiratory Disease: Current Limitations and Perspectives

被引:10
作者
Lhermie, Guillaume [1 ]
Toutain, Pierre-Louis [2 ,3 ]
El Garch, Farid [4 ]
Bousquet-Melou, Alain [2 ,3 ]
Assie, Sebastien [5 ]
机构
[1] Cornell Univ, Coll Vet Med, Dept Populat Med & Diagnost Sci, Ithaca, NY 14853 USA
[2] INRA, TOXALIM, UMR1331, Toulouse, France
[3] Univ Toulouse, INPT, ENVT, EIP,UPS, Toulouse, France
[4] Vetoquinol, Global Drug Dev, Lure, France
[5] INRA, Biol Epidemiol & Anal Risque Sante Anima BioEpAR, UMR1300, Nantes, France
来源
FRONTIERS IN VETERINARY SCIENCE | 2017年 / 4卷
关键词
antimicrobial use; decreased regimen; early treatment; fluoroquinolone; cattle; bovine respiratory disease complex; veterinary precision medicine; MANNHEIMIA-HAEMOLYTICA; INOCULUM SIZE; COMPARATIVE EFFICACY; ESCHERICHIA-COLI; SINGLE INJECTION; YOUNG BULLS; DRUG-USE; CALVES; MARBOFLOXACIN; RESISTANCE;
D O I
10.3389/fvets.2017.00143
中图分类号
S85 [动物医学(兽医学)];
学科分类号
0906 ;
摘要
The therapeutic efficacy of an early treatment protocol with an infection-stage adjusted fluoroquinolone regimen was evaluated in a field study on young bulls (YBs) presenting signs of bovine respiratory disease (BRD). A total of 195 YB (Charolais, Limousin, and Rouge-des-Pres breeds) from 6 farms implementing or not prophylactic antimicrobial treatments (PROPHY or absence) were randomly assigned to 1 of 2 experiment groups based on time of detection of BRD and first-line marbofloxacin regimen, early adjusted dose [Early 2 (E2)] or late standard dose [Late 10 (L10)]. Each YB was administered orally a reticulo-rumen bolus, allowing continuous monitoring of ruminal temperature. In the E2 group, YB presenting early signs of BRD, i.e., an increase in ruminal temperature over 40.2 degrees C and persisting more than 12 h, confirmed by a clinical examination showing no or mild signs of BRD, were given 2 mg/kg of marbofloxacin. In the L10 group, YBs presenting moderate or severe signs of BRD at visual inspection, confirmed at clinical examination, were given 10 mg/kg of marbofloxacin. If needed, YBs were given a relapse treatment. The YBs were followed for 30 days. The proportions of first and relapse treatments were calculated, as well as the therapeutic efficacy at day 10. In the E2 group, the first-line treatments' proportion was significantly higher (P < 0.05), while the relapse treatments' proportion tended to be higher (P = 0.08), than in the L10 group. Evolution of clinical scores (CSs) of diseased YB was followed for 10 days. In both groups, CS and rectal temperature decreased significantly 24 h after treatment (P < 0.05). Treatment incidences (TI) representing antimicrobial consumption assessed on used daily doses (UDD) were calculated. Antimicrobial consumption of marbofloxacin and relapse treatments were not significantly different between the groups. These values were strongly influenced by the recourse to a prophylactic antimicrobial treatment, accounting for more than 90% of the antimicrobial amount in the herds implementing prophylaxis. The higher number of treatments in the groups treated on the basis of ruminal temperature monitoring, the accuracy of the detection method, and the necessary conditions to implement precision antimicrobial therapy in the field are discussed in this article.
引用
收藏
页数:9
相关论文
共 44 条
[1]   Voluntary ban on cephalosporin use in Danish pig production has effectively reduced extended-spectrum cephalosporinase-producing Escherichia coli in slaughter pigs [J].
Agerso, Yvonne ;
Aarestrup, Frank M. .
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2013, 68 (03) :569-572
[2]   Incidence of respiratory disorders during housing in non-weaned Charolais calves in cow-calf farms of Pays de la Loire (western France) [J].
Assié, S ;
Seegers, H ;
Beaudeau, F .
PREVENTIVE VETERINARY MEDICINE, 2004, 63 (3-4) :271-282
[3]   Exposure to pathogens and incidence of respiratory disease in young bulls on their arrival at fattening operations in France [J].
Assie, S. ;
Seegers, H. ;
Makoschey, B. ;
Desire-Bousquie, L. ;
Bareille, N. .
VETERINARY RECORD, 2009, 165 (07) :195-199
[4]  
Confer Anthony W., 2009, Animal Health Research Reviews, V10, P145, DOI 10.1017/S1466252309990193
[5]   Randomized, non-inferiority trial comparing a nitric oxide releasing solution with a macrolide antibiotic for control of bovine respiratory disease in beef feedlot calves at high-risk of developing respiratory tract disease [J].
Crepieux, T. ;
Miller, C. ;
Regev-Shoshani, G. ;
Schaefer, A. ;
Dorin, C. ;
Alexander, T. ;
Timsit, E. .
RESEARCH IN VETERINARY SCIENCE, 2016, 105 :216-221
[6]   The medicine and epidemiology of bovine respiratory disease in feedlots [J].
Cusack, PMV ;
McMeniman, N ;
Lean, IJ .
AUSTRALIAN VETERINARY JOURNAL, 2003, 81 (08) :480-487
[7]   Antibiotics used most commonly to treat animals in Europe [J].
De Briyne, N. ;
Atkinson, J. ;
Pokludova, L. ;
Borriello, S. P. .
VETERINARY RECORD, 2014, 175 (13) :325
[8]   Experimental induction of pneumonic pasteurellosis in calves by intratracheal infection with Pasteurella multocida biotype A:3 [J].
Dowling, A ;
Hodgson, JC ;
Schock, A ;
Donachie, W ;
Eckersall, PD ;
McKendrick, IJ .
RESEARCH IN VETERINARY SCIENCE, 2002, 73 (01) :37-44
[10]  
EMA, 2013, REV ESVAC REFL PAP C, V44, P1